Exhalation of infectious micrometer-sized particles has been strongly implicated in respiratory infection spread. An important fundamental question is then the fate of infectious exhaled particles in indoor spaces, i.e., whether they will remain suspended in an aerosol until ventilation leads to their clearance or whether they will deposit, and if so, on what surfaces in an indoor space. We investigated the interplay between deposition and ventilation using model experiments with a breathing simulator manikin in an office environment. The breathing simulator utilized physiologically correct exhalation and inhalation breathing waveforms as well as an anatomically correct manikin. The simulator output fluorescein-doped particles with a volume distribution spanning the 1–3 μm range. The office environment was a 344 m3 room equipped with desks. Four different test conditions were created by changing the simulator location and via different air change rates and MERV ratings of filters in the HVAC system. We found that the rate of ventilation exceeds the rate of deposition on all surfaces (quantified by Stanton numbers, which were below unity) with several important exceptions: (1) surfaces close to (within 2 m of) the simulator; and (2) non-passive surface exteriors (return grilles and diffusers). A detectable decrease in Stanton number with distance suggests that the room environment cannot be approximated as truly well-mixed. The finding of enhanced deposition on non-passive surfaces at all distances from the room highlights that infectious particles may preferentially deposit on such surfaces in indoor spaces. Finally, while our results highlight particular surfaces with enhanced deposition, our results confirm the importance of ventilation in a room as a means to reduce infectious aerosol particle concentrations, as in large part the clearance for particles appears to occur by ventilation.
Bibliographical noteFunding Information:
We wish to thank William Baker from Mayo Clinic Respiratory Care for allowing use of the respiratory manikin as well as Eric Heins, Well Living Lab Director of Building Operations, for assisting with continued acquisition of materials for these experiments. We thank Dr. Meng Kong of Well Living Lab for assistance in preparing Fig. 1e.
This study was funded by Delos Living, LLC. However, Delos Living, LLC, had no input on any part of the trial process.
© 2021 Elsevier Ltd
- Airborne virus transmission
- Indoor air
- Particle deposition